Informa plc Bundle
How did Informa plc become a global events and academic publishing leader?
In 2018 Informa plc transformed the exhibitions market by acquiring UBM for about £3.9 billion, accelerating its shift from a UK trade publisher to a diversified B2B events, data and scholarly research platform.
Founded in 1998 via the merger of IBC Group plc and LLP Group, Informa now operates Informa Markets, Informa Connect, Informa Tech and Taylor & Francis, serving millions across 30+ industries and generating roughly £3.2 billion in 2023 with 2024 revenue guidance near £3.45–£3.50 billion.
What is Brief History of Informa plc Company? Explore key strategic deals, diversification into events, intelligence and publishing, and its scale after the UBM acquisition. See Informa plc Porter's Five Forces Analysis
What is the Informa plc Founding Story?
Founding Story of Informa plc began with a strategic merger on 1 December 1998 that combined two UK specialist information and events businesses to create a platform focused on sector-specific intelligence and professional forums.
The merger of IBC Group plc and LLP Group plc formed Informa Group plc under CEO David Gilbertson, aiming to monetise demand for trusted, domain-specific knowledge via conferences, subscriptions and training.
- Merger date: 1 December 1998
- First CEO: David Gilbertson
- Founding model: paid conferences, subscriptions, journals, directories, training
- Heritage includes Taylor & Francis (est. 1852) and Lloyd’s List (est. 1734)
Informa plc history is rooted in legacy publishers and conference businesses; the merger was executed using public equity from two listed companies, creating scale rather than a venture-funded startup and setting the stage for later M&A-driven growth that would include acquisitions like IIR and, subsequently, major deals documented in the broader Informa plc timeline; see the detailed Marketing Strategy of Informa plc article for related strategic context.
Informa plc SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of Informa plc?
Early Growth and Expansion traces Informa plc history from a publishing-led group into a global events and information business, driven by acquisitions, subscription economics and geographic expansion across Europe, North America and Asia.
Post-merger integration combined publishing and events calendars, enabled cross-selling of sponsorships and subscriptions, and extended sector coverage from maritime and finance into life sciences, telecoms and engineering while opening regional offices across Europe and North America.
Market preference for specialist brands with paid-content economics and recurring revenue reinforced Informa company background as a portfolio of niche information and events assets with predictable cashflows.
The 2004 merger with Taylor & Francis created a combined FTSE-listed entity and added a high-margin, subscription-led academic publishing arm; Taylor & Francis today publishes over 2,700 journals and more than 150,000 book titles, materially diversifying revenue and strengthening US and academic market exposure.
Acquisition of IIR Holdings for about £768 million expanded Informa plc timeline into a global conference franchise across North America, EMEA and APAC, increasing scale in exhibitions, training and certification programs and enlarging delegate marketing capability.
The group built data and subscription products around events communities to boost pricing power and sponsorship yields, and maintained must-attend verticals plus cost discipline to navigate the 2008–2009 downturn while completing selective bolt-on acquisitions.
Under CEO Stephen A. Carter, the 2014–2017 growth program reorganized Informa corporate evolution around customer markets, invested in flagship brands, digital lead-generation and marketing services, and accelerated exhibitions growth in the US and China.
The ~£3.9bn purchase of UBM created the world’s largest B2B events group by revenue and large-scale shows, adding strength in healthcare, technology, fashion and design and prioritizing data, audience marketing and geo-cloning of hero brands.
COVID-19 forced a rapid shift to virtual and hybrid formats, cost reduction and liquidity preservation. In 2022 Informa sold Pharma Intelligence (Citeline) at an enterprise value of about $2.3 billion, focusing the group on live events and academic publishing while keeping selected data partnerships.
Exhibitions recovered strongly in China and the US post-pandemic. In 2024 Informa completed a strategic combination with TechTarget, scaling a B2B technology demand-generation and data platform while retaining Informa Tech events and content as audience engines; group guidance for 2024 flagged revenue of £3.45–£3.50bn, adjusted operating profit of £960m–£1.0bn and free cash flow of £650m+.
For additional context on market positioning and competitive dynamics, see the article Competitors Landscape of Informa plc.
Informa plc PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What are the key Milestones in Informa plc history?
Milestones, innovations and challenges in the Informa plc history trace its shift from publishing to a global events and information platform, driven by strategic M&A, digital transitions, and portfolio pivots that reinforced recurring journal revenues and scalable flagship exhibitions.
| Year | Milestone |
|---|---|
| 1998 | Formation created an integrated paid content + conferences model, an early 'insight + platform' approach. |
| 2004 | Merger with Taylor & Francis scaled academic publishing and later enabled broad open access options across hundreds of journals. |
| 2005–2006 | IIR acquisition built one of the world’s largest conference portfolios and standardized delegate marketing and sponsorship packaging. |
| 2018 | UBM acquisition positioned the group as global exhibitions leader across healthcare, fashion, pharma and design with data-driven exhibitor ROI tools. |
| 2020–2021 | Pandemic forced a rapid pivot to virtual matchmaking and year-round digital delivery while protecting balance sheet strength and flagship brands. |
| 2022 | Divestment of Pharma Intelligence at about £1.8–£1.9bn cash proceeds (~US$2.3bn EV) refocused capital on live platforms and publishing. |
| 2023–2024 | Post‑pandemic reopening, notably China recovery, raised attendance and exhibitor yields; TechTarget combination added first‑party intent data and ABM capabilities. |
Informa’s innovations combined community-driven conferences with paid insight products, evolving into data-led exhibitor ROI tools and subscription journal revenue; recent moves added first‑party intent data via TechTarget. The group reported maintaining FTSE 100 standing and investment‑grade metrics while advancing sustainability through FasterForward and inclusion initiatives.
Early integration of paid content and events created a repeatable community flywheel linking subscriptions, conferences and sponsorships.
Taylor & Francis merger expanded journal portfolio to thousands of titles and accelerated open access options across hundreds of journals.
IIR integration standardized program design, delegate marketing and sponsorship packaging across a global conference network.
UBM deal brought mega‑brands and developed data-driven exhibitor ROI tools, increasing pricing power for flagship events.
Pandemic-era platforms enabled year‑round engagement, virtual networking and measurable digital demand solutions for exhibitors.
TechTarget combination expanded first‑party intent signals, content syndication and ABM capabilities for technology marketers.
Key challenges included cyclic shocks in 2008–09 and 2020, digital disruption of legacy publishing, and rising niche competition; responses were portfolio rotation, platform M&A and data‑led customer marketing. These moves produced a stronger revenue mix: recurring journals income, scaled exhibitions with pricing power, and always‑on digital demand solutions aligned to measurable ROI and community engagement.
Divestments such as Pharma Intelligence freed capital to reinvest in live platforms and core publishing, sharpening strategic focus.
Rapid build-out of virtual event infrastructure and year‑round digital content preserved customer relationships during venue closures.
Rising niche operators required targeted M&A and product differentiation to protect pricing and market share.
FasterForward initiatives aimed to reduce carbon and improve event inclusivity, responding to stakeholder ESG demands.
Focus shifted toward recurring journal subscriptions and high‑yield flagship exhibitions to stabilize long‑term margins.
Reopening and China tailwinds in 2023–2024 restored attendance and exhibitor yields, supporting near‑term revenue recovery.
For further context on market positioning and target audiences see Target Market of Informa plc
Informa plc Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What is the Timeline of Key Events for Informa plc?
Timeline and Future Outlook of Informa plc: a concise chronology from 1734 origins through major mergers (Taylor & Francis, IIR, UBM, TechTarget) to FY24 scale and 2025 geographic and data-led growth strategies, highlighting financial pivots, divestments and strengthened free cash flow.
| Year | Key Event |
|---|---|
| 1734 | Lloyd’s List founded; later became part of LLP Group and eventually integrated into the Informa corporate ancestry. |
| 1852 | Taylor & Francis founded in London by Richard Taylor and William Francis, later merging with Informa in 2004. |
| 1973 | IIR (Institute for International Research) founded by Irvine Laidlaw; acquired by Informa in mid-2000s to scale conferences. |
| 1998 | 1 Dec: Informa Group plc formed via merger of IBC Group plc and LLP Group plc; David Gilbertson becomes CEO. |
| 2004 | Merger with Taylor & Francis creates a leading academic and professional publishing division within Informa. |
| 2005–2006 | Acquisition of IIR for approximately £768m, significantly expanding global conferences and exhibitions. |
| 2013 | Stephen A. Carter appointed Group CEO and initiates a portfolio sharpening programme to refocus the business. |
| 2018 | Acquisition of UBM for ~£3.9bn, establishing Informa as a global leader in exhibitions and events. |
| 2020 | COVID-19 forces shutdown of physical events; rapid pivot to virtual and hybrid event formats and digital offerings. |
| 2022 | Sale of Pharma Intelligence for an enterprise value of ~$2.3bn and divestment of Maritime Intelligence, strengthening the balance sheet. |
| 2023 | Strong exhibitions recovery supported by China reopening and resilient global trade shows. |
| 2024 | Combination with TechTarget closes, creating a scaled B2B tech data and demand-generation platform; FY24 guidance: revenue £3.45–£3.50bn, adj. operating profit £960m–£1.0bn, FCF £650m+. |
| 2025 | Continued expansion of flagship shows across US, EMEA and APAC; deeper integration of intent data with events and content; hybrid OA strategies at Taylor & Francis drive growth. |
Management targets geographic cloning of major shows into Middle East, India, Southeast Asia and China to capture faster-growing markets and compound revenue growth.
The TechTarget combination accelerates expansion of data-led marketing and intent-driven advertising across Informa Tech audiences to drive higher-margin recurring revenue.
Taylor & Francis is scaling hybrid open-access models and research workflow tools to grow subscriptions and article processing revenues while supporting institutional customers.
Focus on rising margins and strong free cash flow supports progressive dividends and buybacks; divestments (Pharma Intelligence) improved net debt metrics and financial flexibility.
For a detailed corporate chronology and additional milestones, see Brief History of Informa plc
Informa plc Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
- What is Competitive Landscape of Informa plc Company?
- What is Growth Strategy and Future Prospects of Informa plc Company?
- How Does Informa plc Company Work?
- What is Sales and Marketing Strategy of Informa plc Company?
- What are Mission Vision & Core Values of Informa plc Company?
- Who Owns Informa plc Company?
- What is Customer Demographics and Target Market of Informa plc Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.